Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, across generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy (MMN) and ...
EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H'28 ...
Time to get your systems in order, Aquarius. With the Sun in Cancer and your sixth house of health and routines until July 22—and Mercury retrograde here until the 23rd—you’ll be fine-tuning ...
Mytoi is a Japanese-inspired garden managed by The Trustees of Reservations, the Massachusetts-based conservation ...
Use this map to plan your route and discover just how close you are to this enchanting destination. So grab your camera, put ...
Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results